The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 05, 2022

Filed:

Dec. 18, 2018
Applicants:

University of Cincinnati, Cincinnati, OH (US);

Cincinnati Children's Hospital Medical Center, Cincinnati, OH (US);

Inventors:

Debajyoti Ghosh, Cincinnati, OH (US);

Tesfaye Mersha, Cincinnati, OH (US);

Jonathan A. Bernstein, Cincinnati, OH (US);

Assignees:

University of Cincinnati, Cincinnati, OH (US);

Children's Hospital Medical Center, Cincinnati, OH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6883 (2018.01); A61K 31/56 (2006.01); G16B 30/10 (2019.01); A61P 17/00 (2006.01); C12Q 1/686 (2018.01); C12Q 1/6806 (2018.01); G16B 40/20 (2019.01); G16B 40/30 (2019.01); G16B 20/00 (2019.01); G16B 25/00 (2019.01);
U.S. Cl.
CPC ...
A61K 31/56 (2013.01); A61P 17/00 (2018.01); C12Q 1/686 (2013.01); C12Q 1/6806 (2013.01); C12Q 1/6883 (2013.01); G16B 20/00 (2019.02); G16B 30/10 (2019.02); G16B 40/20 (2019.02); G16B 40/30 (2019.02); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/158 (2013.01); G16B 25/00 (2019.02);
Abstract

Provided herein is a method of diagnosing and treating a subject suffering from atopic dermatitis (AD), the method comprising: (a) obtaining a skin biopsy from a subject suspected of suffering from AD; (b) determining a level of RNA expression in the skin biopsy of genes selected from the 89ADGES gene panel; (c) comparing the determined level of RNA expression of the selected genes to the level of RNA expression of the selected genes in a reference sample comprising RNA expression products from normal healthy skin cells; (d) diagnosing the subject as suffering from AD when specific genes are up-regulated compared to the reference sample and when specific genes are down-regulated compared to the reference sample; and (e) treating the subject with a therapy effective for the treatment of AD. Methods of managing treatment of a subject suffering from AD are also provided.


Find Patent Forward Citations

Loading…